AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Silo Pharma, Inc. Director's Dealing 2012

Dec 27, 2012

35304_dirs_2012-12-27_a9a351db-1edb-4a05-b7a1-91fa9abda64a.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Gold Swap Inc (GDSW)
CIK: 0001514183
Period of Report: 2012-11-29

Reporting Person: WHALEHAVEN CAPITAL FUND LTD (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
COMMON STOCK	5519700	Direct